PRS45 - COST-EFFECTIVENESS OF BEDAQUILINE VERSUS INJECTABLE STANDARD-OF-CARE AGENTS FOR THE TREATMENT OF DRUG-RESISTANT TUBERCULOSIS (DR-TB) IN RUSSIA, INDIA, AND SOUTH AFRICA- BREAKTHROUGH INNOVATION DRIVING DOWN COST OF TREATMENT SUCCESS
Abstract
Authors
A. Ionescu M.A. Agnarson C. Kambili J. Kfoury W. Steven V. Singh A. Williams A. Thomas